Terry Fei Fan Ng
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Terry Fei Fan Ng has a total of 694 co-authors. Here are the top co-authors by number of shared publications:
- Eric Delwart
Department Laboratory Medicine, University of California San Francisco, San Francisco, CA 94143, USA
22 shared publications - Rachel L. Marine
Division of Viral Diseases, Centers for Disease Control and Prevention, Atlanta, GA, USA
16 shared publications W. Allan Nix
Division of Viral Diseases, Centers for Disease Control and Prevention
13 shared publicationsM. Steven Oberste
Division of Viral Diseases, Centers for Disease Control and Prevention
12 shared publicationsNikola O. Kondov
Blood Systems Research Institute, San Francisco, CA, USA
11 shared publicationsXutao Deng
Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, California 94118, USA
11 shared publications
Latest Publications
- 4 November 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (5) , 977-984
Investigation of Dinga Dinga: A Cluster of Bilateral Lower-Extremity Tremors—Bundibugyo District, Uganda, 2023–2024
: In September 2023, a cluster of unexplained illness in women affecting their ability to stand/walk was reported at Bundibugyo Hospital, Uganda. Field investigations were conducted to verify reports, conduct active case finding, and identify potential causes using a hypothesis-generating questionnaire, a neurological examination tool, and a standardized laboratory panel. As of January 31, 2025, 136 patients were identified; all were female. Among 108 with age data, the median age was 18 years old, and all but one lived in Bundibugyo District. All reported bilateral lower-extremity tremors interfering with their ability to stand/walk that resolved when sitting or lying down. Of 75 women evaluated, 33 (44%) were acutely symptomatic at assessment. Tremors lasted between 4 days and 3 months. Of 90 women who provided symptom recurrence information, 20 (22%) reported recurrent episodes. No shared environmental exposures of concern were identified among 76 patients with data. Although limited female-specific exposures were noted, no known toxins were identified among patients. Blood specimens were submitted for laboratory testing, and 24 of 93 (26%) tested positive for Plasmodium . One of 34 (3%) tested positive for Shigella spp. Three of 87 (3%) were positive for Ekpoma virus 2 (EKV2), and 41 of 80 (51%) were anti-EKV2 IgG positive. Metagenomic sequencing confirmed two of the EKV2 cases and identified rickettsiae-specific reads in one individual. It is still unknown whether the cause is an infectious agent or an environmental toxin. This outbreak highlights the importance of strong field epidemiology and laboratory capacity in investigating emerging neurological syndromes.
- 4 November 2026
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 115 (5) , 977-984
Investigation of Dinga Dinga: A Cluster of Bilateral Lower-Extremity Tremors—Bundibugyo District, Uganda, 2023–2024
: In September 2023, a cluster of unexplained illness in women affecting their ability to stand/walk was reported at Bundibugyo Hospital, Uganda. Field investigations were conducted to verify reports, conduct active case finding, and identify potential causes using a hypothesis-generating questionnaire, a neurological examination tool, and a standardized laboratory panel. As of January 31, 2025, 136 patients were identified; all were female. Among 108 with age data, the median age was 18 years old, and all but one lived in Bundibugyo District. All reported bilateral lower-extremity tremors interfering with their ability to stand/walk that resolved when sitting or lying down. Of 75 women evaluated, 33 (44%) were acutely symptomatic at assessment. Tremors lasted between 4 days and 3 months. Of 90 women who provided symptom recurrence information, 20 (22%) reported recurrent episodes. No shared environmental exposures of concern were identified among 76 patients with data. Although limited female-specific exposures were noted, no known toxins were identified among patients. Blood specimens were submitted for laboratory testing, and 24 of 93 (26%) tested positive for Plasmodium . One of 34 (3%) tested positive for Shigella spp. Three of 87 (3%) were positive for Ekpoma virus 2 (EKV2), and 41 of 80 (51%) were anti-EKV2 IgG positive. Metagenomic sequencing confirmed two of the EKV2 cases and identified rickettsiae-specific reads in one individual. It is still unknown whether the cause is an infectious agent or an environmental toxin. This outbreak highlights the importance of strong field epidemiology and laboratory capacity in investigating emerging neurological syndromes.
- Open Access
- 27 March 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70879
Diversity of Rhinovirus and Enterovirus Infections Among Pediatric Patients Hospitalized in Wisconsin, 2022–2023
Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022–2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type. During September 2022–April 2023, five Wisconsin pediatric hospitals submitted five RV/EV‐positive specimens weekly to CDC. Viral typing was performed using partial viral protein (VP) 4/VP2 (RV) and VP1 (EV) sequencing. Wisconsin Department of Health Services abstracted demographic, comorbid condition, and hospitalization course information from patient medical records. Ninety‐six patients were included in this investigation. RV‐C ( n = 40, 42%) and RV‐A ( n = 31, 32%) were the most frequently detected species, with 46 RV and 5 EV types identified. The median age was 2.5 (IQR: 0.7–5.5) years. Seventy‐one (74%) children had at least one comorbid condition. Asthma was more common among children with RV‐C infections ( n = 12, 30%) compared with other RVs ( n = 3, 9%) ( p = 0.02). RV‐A and RV‐C were important contributors to severe pediatric respiratory infection in Wisconsin. Molecular typing showed virus divergence typically observed during season‐long investigations. Year‐round molecular characterization is needed to better understand the contribution of RV/EV types to severe pediatric respiratory illness.
- 27 March 2026
- Published by Wiley in Journal of Medical Virology
- Vol. 98 (4) , e70879
Open AccessDiversity of Rhinovirus and Enterovirus Infections Among Pediatric Patients Hospitalized in Wisconsin, 2022–2023
Severe rhinovirus (RV)/enterovirus (EV) respiratory infections in pediatric patients increased in the US during 2022–2023. This study aimed to characterize RV/EV genetic diversity among hospitalized children in Wisconsin and describe demographic and clinical factors of patients by RV/EV type. During September 2022–April 2023, five Wisconsin pediatric hospitals submitted five RV/EV‐positive specimens weekly to CDC. Viral typing was performed using partial viral protein (VP) 4/VP2 (RV) and VP1 (EV) sequencing. Wisconsin Department of Health Services abstracted demographic, comorbid condition, and hospitalization course information from patient medical records. Ninety‐six patients were included in this investigation. RV‐C ( n = 40, 42%) and RV‐A ( n = 31, 32%) were the most frequently detected species, with 46 RV and 5 EV types identified. The median age was 2.5 (IQR: 0.7–5.5) years. Seventy‐one (74%) children had at least one comorbid condition. Asthma was more common among children with RV‐C infections ( n = 12, 30%) compared with other RVs ( n = 3, 9%) ( p = 0.02). RV‐A and RV‐C were important contributors to severe pediatric respiratory infection in Wisconsin. Molecular typing showed virus divergence typically observed during season‐long investigations. Year‐round molecular characterization is needed to better understand the contribution of RV/EV types to severe pediatric respiratory illness.
- Open Access
- 20 August 2025
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (9) , e0149222
Type-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains
We developed a type-specific Enterovirus D68 (EV-D68) real-time RT-PCR (rRT-PCR) assay termed CDC2022, which targets sequences encoding conserved amino acid regions of all extant EV-D68 strains. We targeted three motifs conserved among all strains in the last 60 years. The assay achieved 100% (281/281) sensitivity and 100% (344/344) specificity when tested with a collection of 625 respiratory specimens, compared to the gold-standard EV semi-nested VP1 PCR and sequencing assay (snPCR/Seq). CDC2022 gave negative results with 289/289 non-target viruses, including 104 EV A-D isolates, 165 rhinovirus (RV) isolates or clinical specimens, and 14 other common respiratory viruses. The limit of detection (LOD) of the CDC2022 assay is 361 copies per reaction, as determined using serially diluted RNA transcripts. It can detect as few as 0.28 CCID 50 per reaction with titrated isolates. An in silico “phylo-primer-mismatch" analysis was performed to visualize primer/probe mismatches and to compare CDC2022 with other EV-D68 rRT-PCR assays. It showed that CDC2022 has the fewest primer/probe mismatches among all assays analyzed and is suitable for all clades. As a type-specific assay targeting conserved amino acids, the CDC2022 assay allowed detection of newer strains from 2024. The CDC 2022 assay could provide a critical tool for molecular surveillance of EV-D68. IMPORTANCE: EV-D68 has caused recurring respiratory disease outbreaks in the United States since 2014. As recurrent outbreaks and continued virus evolution are expected for EV-D68, the CDC2022 rRT-PCR provides a robust test that detects known strains as well as potential emerging strains. This type-specific assay approach is critical for national EV-D68 surveillance and clinical diagnostics. An in silico “phylo-primer-mismatch" approach is invented to show EV-D68 assay robustness, but it has utility in new molecular tests for pathogen detection.
- 20 August 2025
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 63 (9) , e0149222
Open AccessType-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains
We developed a type-specific Enterovirus D68 (EV-D68) real-time RT-PCR (rRT-PCR) assay termed CDC2022, which targets sequences encoding conserved amino acid regions of all extant EV-D68 strains. We targeted three motifs conserved among all strains in the last 60 years. The assay achieved 100% (281/281) sensitivity and 100% (344/344) specificity when tested with a collection of 625 respiratory specimens, compared to the gold-standard EV semi-nested VP1 PCR and sequencing assay (snPCR/Seq). CDC2022 gave negative results with 289/289 non-target viruses, including 104 EV A-D isolates, 165 rhinovirus (RV) isolates or clinical specimens, and 14 other common respiratory viruses. The limit of detection (LOD) of the CDC2022 assay is 361 copies per reaction, as determined using serially diluted RNA transcripts. It can detect as few as 0.28 CCID 50 per reaction with titrated isolates. An in silico “phylo-primer-mismatch" analysis was performed to visualize primer/probe mismatches and to compare CDC2022 with other EV-D68 rRT-PCR assays. It showed that CDC2022 has the fewest primer/probe mismatches among all assays analyzed and is suitable for all clades. As a type-specific assay targeting conserved amino acids, the CDC2022 assay allowed detection of newer strains from 2024. The CDC 2022 assay could provide a critical tool for molecular surveillance of EV-D68. IMPORTANCE: EV-D68 has caused recurring respiratory disease outbreaks in the United States since 2014. As recurrent outbreaks and continued virus evolution are expected for EV-D68, the CDC2022 rRT-PCR provides a robust test that detects known strains as well as potential emerging strains. This type-specific assay approach is critical for national EV-D68 surveillance and clinical diagnostics. An in silico “phylo-primer-mismatch" approach is invented to show EV-D68 assay robustness, but it has utility in new molecular tests for pathogen detection.
- Open Access
- 5 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4378
Genome Announcement of Four Parechovirus A3 Isolates from the United States of America
We report the complete genome sequences of four parechovirus-A3 (PeV-A3) isolates from Children’s Mercy Kansas City (CMKC), United States of America (USA): PeV-A3-MO-12-CMKC/CSF/MO/USA/2012 (isolated in 2012 from cerebrospinal fluid), PeV-A3-8C-CMKC/CSF/MO/USA/2022/ (isolated in 2022 from cerebrospinal fluid), PeV-A3-9C-CMKC/CSF/MO/USA/2022 (isolated in 2022 from cerebrospinal fluid), and PeV-A3-11B-CMKC/Blood/MO/USA/2022 (isolated in 2022 from blood). Sequence analysis revealed multiple mutations throughout the genome of the PeV-A3 isolates in comparison to the prototypic PeV-A3 A308/99 reference sequence (AB084913). Several unique amino acid changes were observed in the PeV-A3 isolates from 2022 that were absent in the PeV-A3 isolate from 2012. Phylogenetic analysis comparison determined that the sequenced PeV-A3 isolates from 2022 cluster together as a separate clade.
- 5 May 2025
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (9) , 4378
Open AccessGenome Announcement of Four Parechovirus A3 Isolates from the United States of America
We report the complete genome sequences of four parechovirus-A3 (PeV-A3) isolates from Children’s Mercy Kansas City (CMKC), United States of America (USA): PeV-A3-MO-12-CMKC/CSF/MO/USA/2012 (isolated in 2012 from cerebrospinal fluid), PeV-A3-8C-CMKC/CSF/MO/USA/2022/ (isolated in 2022 from cerebrospinal fluid), PeV-A3-9C-CMKC/CSF/MO/USA/2022 (isolated in 2022 from cerebrospinal fluid), and PeV-A3-11B-CMKC/Blood/MO/USA/2022 (isolated in 2022 from blood). Sequence analysis revealed multiple mutations throughout the genome of the PeV-A3 isolates in comparison to the prototypic PeV-A3 A308/99 reference sequence (AB084913). Several unique amino acid changes were observed in the PeV-A3 isolates from 2022 that were absent in the PeV-A3 isolate from 2012. Phylogenetic analysis comparison determined that the sequenced PeV-A3 isolates from 2022 cluster together as a separate clade.
- 24 January 2023
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 12 (1) , e0073522
Nearly Complete Genome Sequences of Type 2 Sabin-Like Polioviruses from Northern Nigerian Poliovirus Surveillance, 2016 to 2018
We sequenced 109 type 2 Sabin-like poliovirus isolates that had been collected from acute flaccid paralysis patients or healthy children in Nigeria. Understanding the genetic makeup of these viruses may contribute to polio eradication efforts.
- 24 January 2023
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 12 (1) , e0073522
Nearly Complete Genome Sequences of Type 2 Sabin-Like Polioviruses from Northern Nigerian Poliovirus Surveillance, 2016 to 2018
We sequenced 109 type 2 Sabin-like poliovirus isolates that had been collected from acute flaccid paralysis patients or healthy children in Nigeria. Understanding the genetic makeup of these viruses may contribute to polio eradication efforts.
- Open Access
Type-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains
Enterovirus D68 (EV-D68) has caused recurring respiratory disease outbreaks in the United States since 2014. The dominant circulating EV-D68 strain has evolved from clade B1 to the more recent B2 and B3 clades. As recurrent outbreaks and continued virus evolution are expected for EV-D68, a robust real-time PCR assay that detects known strains as well as potential emerging strains is critical for national surveillance and clinical diagnostics. We describe a type-specific EV-D68 real-time RT-PCR (rRT-PCR) assay termed CDC2022, which targets sequences encoding conserved amino acid regions of all extant EV-D68 strains. We targeted three motifs conserved among all strains in the last 60 years. The assay achieved 100% (270/270) sensitivity and 100% (344/344) specificity when tested with a collection of 613 respiratory specimens, compared to the gold-standard EV semi-nested VP1 PCR and sequencing assay (snPCR/Seq). CDC2022 gave negative results with 289/289 non-target viruses, including 104 EV A-D isolates, 165 rhinovirus (RV) isolates or clinical specimens, and 14 other common respiratory viruses. The assay can detect as few as 0.28 CCID 50 per reaction. An in silico “phylo-primer-mismatch” analysis was performed to visualize primer/probe mismatches and to compare CDC2022 with other EV-D68 rRT-PCR assays, including the previous CDC assay (CDC2015) developed in 2014 for clade B1 strains. It showed that CDC2022 has the fewest primer/probe mismatches among all assays analyzed and is suitable for all clades. We additionally tested 11 EV-D68-positive clinical specimens from 2022 that were confirmed by snPCR/Seq, and all were detected. CDC2022 assay could provide a critical tool for molecular surveillance of EV-D68.
Open AccessType-specific EV-D68 real-time RT-PCR assay for the detection of all extant enterovirus D68 strains
Enterovirus D68 (EV-D68) has caused recurring respiratory disease outbreaks in the United States since 2014. The dominant circulating EV-D68 strain has evolved from clade B1 to the more recent B2 and B3 clades. As recurrent outbreaks and continued virus evolution are expected for EV-D68, a robust real-time PCR assay that detects known strains as well as potential emerging strains is critical for national surveillance and clinical diagnostics. We describe a type-specific EV-D68 real-time RT-PCR (rRT-PCR) assay termed CDC2022, which targets sequences encoding conserved amino acid regions of all extant EV-D68 strains. We targeted three motifs conserved among all strains in the last 60 years. The assay achieved 100% (270/270) sensitivity and 100% (344/344) specificity when tested with a collection of 613 respiratory specimens, compared to the gold-standard EV semi-nested VP1 PCR and sequencing assay (snPCR/Seq). CDC2022 gave negative results with 289/289 non-target viruses, including 104 EV A-D isolates, 165 rhinovirus (RV) isolates or clinical specimens, and 14 other common respiratory viruses. The assay can detect as few as 0.28 CCID 50 per reaction. An in silico “phylo-primer-mismatch” analysis was performed to visualize primer/probe mismatches and to compare CDC2022 with other EV-D68 rRT-PCR assays, including the previous CDC assay (CDC2015) developed in 2014 for clade B1 strains. It showed that CDC2022 has the fewest primer/probe mismatches among all assays analyzed and is suitable for all clades. We additionally tested 11 EV-D68-positive clinical specimens from 2022 that were confirmed by snPCR/Seq, and all were detected. CDC2022 assay could provide a critical tool for molecular surveillance of EV-D68.
- 27 April 2022
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (2) , e0256421
VPipe: an Automated Bioinformatics Platform for Assembly and Management of Viral Next-Generation Sequencing Data
Computational infrastructure and bioinformatics analysis are bottlenecks in the application of NGS to viral pathogens. As of September 2021, VPipe has been used by the U.S.
- 27 April 2022
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 10 (2) , e0256421
VPipe: an Automated Bioinformatics Platform for Assembly and Management of Viral Next-Generation Sequencing Data
Computational infrastructure and bioinformatics analysis are bottlenecks in the application of NGS to viral pathogens. As of September 2021, VPipe has been used by the U.S.
- 18 November 2021
- Published by SAGE Publications in Veterinary Pathology
- Vol. 59 (2) , 348-352
A novel herpes-like virus inducing branchial lesions in a tiger shark (Galeocerdo cuvier)
A juvenile, male tiger shark (Galeocerdo cuvier) developed illness after capture in Florida waters and was euthanized. Gross lesions included mild skin abrasions, hepatic atrophy, and coelomic fluid. Histologically, gills contained multifocal lamellar epithelial cell necrosis and thromboses. Scattered gill and esophageal epithelial cells had large, basophilic, intracytoplasmic, and intranuclear inclusions. Ultrastructurally, lamellar epithelial cells contained arrays of intracytoplasmic viral particles and scattered intranuclear nucleocapsids. Capsulated virions were 148 ± 11 nm with an 84 ± 8 nm icosahedral nucleocapsid and an electron-dense core. Next-generation sequencing, quantitative polymerase chain reaction, and in situ hybridization performed on formalin-fixed tissue confirmed a herpes-like viral infection. The viral polymerase shared 24% to 31% protein homology with other alloherpesviruses of fish, indicating a divergent virus. This report documents the pathologic findings associated with a molecularly confirmed novel herpes-like virus in an elasmobranch.
- 18 November 2021
- Published by SAGE Publications in Veterinary Pathology
- Vol. 59 (2) , 348-352
A novel herpes-like virus inducing branchial lesions in a tiger shark (Galeocerdo cuvier)
A juvenile, male tiger shark (Galeocerdo cuvier) developed illness after capture in Florida waters and was euthanized. Gross lesions included mild skin abrasions, hepatic atrophy, and coelomic fluid. Histologically, gills contained multifocal lamellar epithelial cell necrosis and thromboses. Scattered gill and esophageal epithelial cells had large, basophilic, intracytoplasmic, and intranuclear inclusions. Ultrastructurally, lamellar epithelial cells contained arrays of intracytoplasmic viral particles and scattered intranuclear nucleocapsids. Capsulated virions were 148 ± 11 nm with an 84 ± 8 nm icosahedral nucleocapsid and an electron-dense core. Next-generation sequencing, quantitative polymerase chain reaction, and in situ hybridization performed on formalin-fixed tissue confirmed a herpes-like viral infection. The viral polymerase shared 24% to 31% protein homology with other alloherpesviruses of fish, indicating a divergent virus. This report documents the pathologic findings associated with a molecularly confirmed novel herpes-like virus in an elasmobranch.
- 7 October 2021
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 10 (40) , e0072821
Whole-Genome Sequences of Enteroviruses D94 and D111 Isolated from Stool Specimens in Angola
We report the whole-genome sequences of new enterovirus D94 and D111 strains, isolated from a culture from stool specimens collected from acute flaccid paralysis (AFP) cases for poliovirus surveillance in Angola during 2010.
- 7 October 2021
- Published by American Society for Microbiology in Microbiology Resource Announcements
- Vol. 10 (40) , e0072821
Whole-Genome Sequences of Enteroviruses D94 and D111 Isolated from Stool Specimens in Angola
We report the whole-genome sequences of new enterovirus D94 and D111 strains, isolated from a culture from stool specimens collected from acute flaccid paralysis (AFP) cases for poliovirus surveillance in Angola during 2010.
- 21 September 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (10) , 1849
Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis
- 21 September 2021
- Published by Springer Nature in Nature Medicine
- Vol. 27 (10) , 1849
Author Correction: Pan-viral serology implicates enteroviruses in acute flaccid myelitis